ACT 2 Logo

Peptide Therapy

What a peptide actually is, where the FDA rules genuinely stand, and what the evidence supports — answered one compound at a time.

40 questions answered

What is a peptide?

A peptide is a short chain of amino acids — the same building blocks proteins are made of, joined by the same kind of bond, in a shorter chain. Many peptides act as messengers, binding to receptors and changing what a cell does next: insulin, oxytocin and GLP-1 are all peptides. The word is a chemical description rather than a class of medicine, so it tells you nothing about whether a particular peptide has been studied, approved, or made by anyone you should trust.
Peptides, explained

Why does the word peptide cover insulin, semaglutide and unapproved research chemicals?

Because “peptide” describes the shape of a molecule, not its regulatory status or the evidence behind it. Insulin is a peptide with a century of clinical use, semaglutide is a peptide medicine with large randomized trials behind it, and a vial sold online marked “research use only” may hold a peptide no regulator has ever examined. Sorting by chemistry puts all three in one bucket, which is why hearing that someone is “on peptides” tells you almost nothing about what they are taking.
What are peptides?

Are peptides the same as steroids?

No. Anabolic steroids are built on a cholesterol-derived ring structure and act largely at receptors inside the cell, while peptides are chains of amino acids that mostly act at receptors on the cell surface. They are different classes of molecule with different effects, different risks and different legal status. The one thing they share is that several peptides, like steroids, are prohibited under sport anti-doping rules.
How peptides work

What is the difference between peptides and hormones?

The two categories overlap rather than compete: some hormones are peptides and some are not. Insulin, oxytocin and growth hormone are peptide hormones; estradiol and testosterone are steroid hormones built from cholesterol, and thyroid hormone is a third kind again. “Hormone” describes what a molecule does — carry a signal between tissues — while “peptide” describes what it is made of.
Peptides vs. hormones

Are peptides FDA-approved?

Some peptides are FDA-approved and many are not, and the word itself does not tell you which. Insulin, semaglutide, tirzepatide and a number of other peptide drugs are approved medicines with defined indications, reviewed manufacturing and published trial data behind them. The compounded peptides discussed in wellness settings — BPC-157, TB-500, KPV, MOTS-c, epithalon and DSIP among them — are not FDA-approved for any use. Approval attaches to a specific product for a specific indication, never to a chemical category.
Peptides, explained

What did the FDA do to peptides in April 2026?

In April 2026 the FDA removed twelve peptide substances from Category 2 of the interim list it maintains for bulk drug substances used in compounding under section 503A. The reason was procedural — the parties who had nominated those substances withdrew their nominations — and it was not a safety finding about any of them. Removal from Category 2 also does not by itself authorize compounding, so it is not the clearance it is sometimes reported to be.
Peptides, explained

What did the July 2026 FDA advisory committee vote on peptides decide?

In late July 2026 the Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV, TB-500, MOTS-c, epitalon and Semax for inclusion on the 503A Bulks List, on narrow margins and against FDA staff's own recommendation. The committee voted against recommending Emideltide, the substance commonly called DSIP. An advisory committee vote is advice to the agency rather than a decision by it, and it was about eligibility for pharmacy compounding, not about whether any of these compounds works.
Peptides, explained

Does the advisory committee vote mean these peptides are approved now?

No. Formal addition to the 503A Bulks List requires notice-and-comment rulemaking, and that rulemaking had not completed as of September 2026, so nothing about the compounding rules was settled by the vote. Eligibility for compounding is a separate question from drug approval in any case: none of BPC-157, TB-500, KPV, MOTS-c, epithalon or DSIP is an FDA-approved medicine, and the July 2026 vote did not change that. Anyone telling you the matter is settled, in either direction, is ahead of the facts.
Peptides, explained

What does research use only mean on a peptide vial?

It means the contents are sold as a laboratory chemical rather than a medicine, explicitly labeled as not for human consumption. Nobody in that supply chain is accountable for identity, purity, sterility or what the vial actually holds — no pharmacist prepared it, no prescriber authorized it, no regulator reviewed it. Testing of peptides bought that way has repeatedly found products that were not what the label said. The label is not a technicality to be worked around; it marks the absence of everyone who would otherwise stand behind the product.
Are peptides safe?

Is it safe to buy peptides online without a prescription?

No, and sourcing is part of the safety question rather than separate from it. A peptide bought outside the medical supply chain carries no verified identity, purity or sterility, and no clinician has checked it against your history, conditions and other medications. ACT 2 Health does not help anyone obtain peptides outside a prescription: where a peptide is appropriate, it is prescribed after a clinical evaluation and prepared by a licensed compounding pharmacy that can be named.
Are peptides safe?

What is a compounding pharmacy?

A compounding pharmacy is a licensed pharmacy that prepares a medication for an individual patient against a prescription, rather than manufacturing standardized stock for shelves. Under section 503A that preparation is patient-specific, and sterile preparations require particular facilities and procedures. Compounding is a distinct legal pathway from FDA approval — it does not make a preparation approved, generic, or equivalent to a branded drug, and the evidence question for the substance stays exactly where it was. You are entitled to know which pharmacy is filling your prescription.
How peptide therapy is prescribed

How does a legitimate peptide prescription work?

It starts with a clinician licensed in your state who takes a history, reviews your medications and conditions, and orders baseline blood work before anything is prescribed. If a peptide is appropriate, the prescription goes to a licensed compounding pharmacy that prepares it for you specifically, and you leave with a measurable endpoint and a date to be reviewed. The illegitimate route is defined mostly by what it skips: no clinician, no labs, no nameable pharmacy, and no follow-up.
How peptide therapy is prescribed

Do I need blood work before starting peptide therapy?

Yes, and it is the step most worth insisting on. Fatigue, poor recovery, weight change and low libido — the complaints that bring most people to this category — have common causes a panel will find, including thyroid dysfunction, low iron, anemia, insulin resistance and declining testosterone, and every one of those has better-evidenced treatment than any peptide. A baseline is also the only way to tell later whether anything actually changed; see lab testing for what a panel covers.
Lab testing and diagnostics

How do I judge a peptide provider?

Ask whether a clinician licensed in your state is accountable for the decision and whether you will speak to them, whether blood work happens before prescribing rather than after, which pharmacy fills the prescription, and what the regulatory status of the specific substance is. Ask what the evidence actually consists of — a provider willing to say “animal studies” is one whose other claims are worth more — and how you will both know whether it did anything. A good provider will not mind a single one of those questions.
Choosing a peptide provider

What are the warning signs of a peptide clinic to avoid?

Guaranteed outcomes, anti-aging language with nothing measurable attached, long prepaid packages sold before anyone has seen a lab result, dosing advice given without an evaluation, and any seller that does not require a prescription at all. A questionnaire that ends in a shipment is not a clinical evaluation, and a provider who calls a compounded peptide FDA-approved is either uninformed or managing you. A plan with no defined stopping point is a subscription rather than a treatment.
Choosing a peptide provider

Do peptides work?

That question can only be answered one substance at a time, because the category runs from approved medicines to compounds whose entire research base is preclinical. For the approved peptide drugs — insulin and the GLP-1 receptor agonists among them — the trial evidence is substantial. For several of the compounded peptides marketed hardest, including BPC-157, epithalon and DSIP, the research is largely animal and cell work, and popularity has run a long way ahead of proof. Anyone answering for the whole category is not answering.
Peptides, explained

What does it mean when you say a peptide's evidence is preclinical?

Preclinical means the effect has been observed in cells or in animals, not demonstrated in people. That research is real, and it is why these compounds are interesting at all — but it does not transfer automatically, and a great deal of medical history is things that worked in rodents and did not work in humans. Where ACT 2 Health describes a compound whose research base is preclinical, the pages say preclinical rather than implying a human finding that does not exist.
Peptides: hype vs. evidence

Which peptides have the strongest evidence behind them?

The strongest evidence belongs to approved peptide drugs that almost nobody markets as peptide therapy: insulin, the GLP-1 receptor agonists semaglutide and tirzepatide, and several approved peptide medicines used in endocrinology and bone health. Those have randomized trials, defined indications and labeled risks. The compounds usually sold under the peptide-therapy banner sit much further down that scale, on small, old or purely preclinical literature — which is the reverse of how the category is generally advertised.
Peptides, explained

How safe are peptides?

Safety has to be judged one substance at a time, and for most of the compounded peptides the honest answer is that long-term human safety is unstudied. The short-term human safety data that exists for BPC-157, for example, looked acceptable and is small and old; no evidence of harm is not the same as evidence of safety over time. Sourcing belongs inside the safety question too, because a substance of unverified identity and purity carries risks that have nothing to do with the molecule itself.
Are peptides safe?

Are peptides safe because the body already makes them?

No — “your body already makes it” is a statement about origin, not an argument about safety. Your body makes insulin, thyroid hormone and cortisol, each of which causes serious harm at the wrong amount, by the wrong route or at the wrong time, and introducing a signal from outside into a system already regulating it is not a neutral act. The claim also says nothing about what is in the vial, which with an unverified product is the more immediate problem. A signal that changes physiology is a drug, and it deserves the care a drug gets.
Peptides, explained

Are peptides injected or taken by mouth?

Both routes exist, and which one is available depends on the specific peptide. Most peptides studied clinically were given by subcutaneous injection, because peptides are poorly absorbed through the gut; oral capsules and oral dissolving tablets are formulated to work around that problem. ACT 2 Health offers sermorelin as an oral dissolving tablet, and the route for any other peptide is a clinical decision made with your prescriber rather than an option selected from a menu.
Injectable vs. oral peptides

Are oral peptides as effective as injections?

For most peptides that has not been established, and a provider who says otherwise is ahead of the evidence. Peptides are large, fragile molecules that the digestive tract breaks down, which is why nearly all clinical research in this category used injection; oral and dissolving-tablet formats are designed to address absorption, and whether they succeed is usually not published. Sermorelin is the clearest example: every meaningful study of it used an injected route, so an oral dissolving tablet does not inherit that evidence. The honest framing is a monitored trial with a defined endpoint, not an assumption of equivalence.
Injectable vs. oral peptides

How long does it take for a peptide to do anything?

There is no timeline anyone can promise you, and a provider quoting one is selling rather than treating. Where changes are reported on growth-hormone-supporting peptides, sleep quality tends to be mentioned earliest; anything involving body composition is a matter of months and is inseparable from training, protein and sleep. What matters more than a timeline is agreeing in advance what would count as a change, then looking again on a defined date with a genuine willingness to stop.
Starting peptide therapy

What is sermorelin?

Sermorelin is a synthetic peptide that signals the pituitary to release more of the growth hormone your body already makes, rather than supplying growth hormone from outside. Because your own feedback regulation stays intact, the effect is more modest and more variable than injected growth hormone — that is the design rather than a shortcoming. ACT 2 Health offers sermorelin as an oral dissolving tablet prepared by a licensed compounding pharmacy.
Sermorelin ODT

Is sermorelin the same as human growth hormone?

No. Human growth hormone supplies the hormone directly and overrides the body's own control of it, while sermorelin acts one step upstream, prompting the pituitary to release its own growth hormone so the existing feedback loops still apply. That is a real difference in how the two behave, and it is also why sermorelin is not a way to obtain the effects of growth hormone under another name.
Sermorelin: a closer look

Is sermorelin FDA-approved?

Not in the form sold today. Sermorelin was approved in 1997 as Geref for growth hormone deficiency in children and was discontinued in the United States in 2008 for commercial rather than safety reasons. It is now available only as a compounded medication, and compounded medications are not FDA-approved and are not reviewed by the FDA for safety or effectiveness. Sermorelin was also not among the twelve substances the FDA removed from Category 2 of its interim 503A list in April 2026.
Sermorelin ODT

What is BPC-157?

BPC-157 is a synthetic peptide based on a sequence identified in gastric juice — the name stands for body protection compound — studied for a role in tissue repair and in the gut lining. BPC-157 is not FDA-approved for any use; where it is prescribed, it is prepared by a licensed compounding pharmacy under a prescription written for you. The great majority of what is known about it comes from animal work, and the human record is small and old.
BPC-157

Will BPC-157 heal an injury?

No one can tell you that, and BPC-157 has not been shown in human trials to heal injuries. The animal literature on tissue repair is genuinely interesting and is why the compound is discussed at all, but a preclinical finding is not a human result, and BPC-157 is not FDA-approved. Where it is considered, it is considered as possible support alongside the things that actually rebuild tissue — loading, sleep, protein and time — with a defined endpoint and a real willingness to stop.
Repair and recovery

What is TB-500, and what is the Wolverine Stack?

TB-500 is a synthetic fragment related to thymosin beta-4, studied preclinically for a role in tissue repair, and the Wolverine Stack is TB-500 paired with BPC-157. Neither TB-500 nor BPC-157 is FDA-approved, and no published trial compares the pair against either compound used alone — the case for combining them is mechanistic reasoning, not evidence of an additive effect. Stacking two compounds does not double the evidence behind them.
Wolverine Stack

What is KPV?

KPV is a short fragment of alpha-melanocyte-stimulating hormone studied for an anti-inflammatory effect, mostly in preclinical models of gut inflammation. KPV is not FDA-approved, and there is no human trial evidence establishing that it treats any condition; it is the third component of the Repair & Recovery Stack, alongside BPC-157 and TB-500. KPV is not a substitute for treatment of inflammatory bowel disease or any other diagnosed condition.
Repair & Recovery Stack

What is MOTS-c?

MOTS-c is a peptide encoded in mitochondrial rather than nuclear DNA, studied for a role in insulin sensitivity and metabolic regulation — overwhelmingly in cell and animal work. MOTS-c is not FDA-approved, and the phrase “exercise mimetic” often attached to it comes from the laboratory rather than from anything demonstrated in people; it is not a reason to train less. The human data is mostly observational: plasma levels rise with exercise and vary with age.
MOTS-c

What is epithalon?

Epithalon, also spelled epitalon, is a short synthetic peptide derived from epithalamin, a pineal-gland extract studied in the Soviet Union from the 1980s onward, and it is best known for laboratory findings on telomerase. Epithalon is not FDA-approved, and findings about an enzyme in cells are not a demonstration that anything happens to a person's health or lifespan. Its research base is largely older work from one research tradition, not independently replicated in the kind of trials Western regulators rely on.
Epithalon

What is DSIP?

DSIP, delta sleep-inducing peptide, is a short peptide named for an effect observed in rabbits in the 1970s and studied since for roles in sleep and in stress response. DSIP is not FDA-approved, and the human sleep literature behind it is small, old and mixed — it is also the one substance the FDA's advisory committee voted against recommending for the 503A Bulks List in July 2026. Of everything in the ACT 2 Health peptide catalog, DSIP has the weakest case, and it is not a substitute for having a sleep problem properly assessed.
DSIP

Do peptides help you sleep?

No peptide has been shown in robust human trials to treat a sleep disorder, and the two usually raised for sleep both carry caveats: the human evidence for DSIP is small, old and mixed, and sermorelin's link to sleep rests on growth hormone being released mainly during deep sleep rather than on trial outcomes. Persistent poor sleep more often has a findable cause — obstructive sleep apnea, alcohol, thyroid dysfunction, the menopause transition or mood — and those have real treatments. Assessing the sleep itself comes before any peptide conversation.
Peptides for sleep and energy

Do peptides help you recover faster after 45?

The repair peptides most often used for recovery — BPC-157, TB-500 and KPV — rest on preclinical research, have no human trial evidence establishing that they speed recovery, and none of them is FDA-approved. Slower recovery in midlife also has causes that show up on a panel, including declining testosterone, thyroid dysfunction, anemia and untreated poor sleep, and treating those is far better supported than any peptide. Where a peptide is considered at all, it belongs on top of loading, protein and sleep rather than in place of them.
Repair and recovery

Do peptides improve skin and hair?

Cosmetic peptides in topical products are a different category from prescribed peptide therapy, and ACT 2 Health does not claim that any prescribed peptide improves skin or hair. What is actually prescribed here for hair thinning is a compounded 4-in-1 hair loss formulation, which is not a peptide. Skin and hair changes in midlife are frequently driven by thyroid function, iron status and falling estrogen or testosterone, which makes a panel a more useful first step than a peptide.
Peptides for skin and hair

Are peptides banned in sport?

Several are, and a clinically appropriate prescription is not an exemption. BPC-157 and TB-500 appear on the World Anti-Doping Agency's prohibited list, growth-hormone-releasing compounds including sermorelin are prohibited, and a substance with no regulatory approval anywhere can be banned as a non-approved substance regardless of why it was taken. If you compete in a tested sport, raise it before anything is prescribed rather than after.
Peptides for athletes and active adults

Are GLP-1 medications like semaglutide peptides?

Yes — semaglutide and tirzepatide are peptides, and they are the best-evidenced peptides most people will ever be offered, with large randomized trials behind the approved branded medicines. They are almost never discussed as peptide therapy, which says more about how the marketing language developed than about the chemistry. Questions about GLP-1 medications for weight loss are answered in the weight loss topic.
GLP-1s are peptides too

Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.

Still have questions?

We measure first. Then we act.

This page is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.